Restriction-spectrum imaging of bevacizumab-related necrosis in a patient with GBM

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Farid, Nikdokht ^a,b   Almeida Freitas, Daniela B ^a,b,c   White, Nathan S ^a,b   McDonald, Carrie R ^b,d   Muller, Karra A ^e   VandenBerg, Scott R ^e   Kesari, Santosh ^f,g   Dale, Anders M ^a,b,d,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Bevacizumab; Diffusion weighted imaging; Glioblastoma multiforme; Necrosis; Restriction spectrum imaging

Indexed keywords

BEVACIZUMAB; TEMOZOLOMIDE;

ADULT; ARTICLE; AUTOPSY; BRAIN BLOOD VOLUME; BRAIN NECROSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; DIFFUSION WEIGHTED IMAGING; GLIOBLASTOMA; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PERFUSION WEIGHTED IMAGING; RESTRICTION SPECTRUM IMAGING; TUMOR RECURRENCE;

EID: 84891122832     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00258     Document Type: Article

References (10)

1. White NS, McDonald CR, Farid N, Kuperman JM, Kesari S, Dale AM. Improved conspicuity and delineation of high-grade primary and metastatic brain tumors using "restriction spectrum imaging": quantitative comparison with high B-value DWI and ADC. AJNR Am J Neuroradiol (2012) 34(5):958-64. doi: 10.3174/ajnr.A3327
2. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res (2000) 6(6):2189-200.
3. Aronen HJ, Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am (2002) 12(4):501-23. doi:10.1016/S1052-5149(02)00026-6
4. Jeyaretna DS, Curry WT Jr, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR. Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol (2011) 29(7):e159-62. doi:10.1200/JCO.2010.31.4815
5. Mong S, Ellingson BM, Nghiemphu PL, Kim HJ, Mirsadraei L, Lai A, et al. Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls. AJNR Am J Neuroradiol (2012) 33(9):1763-70. doi:10.3174/ajnr.A3053
6. Rieger J, Bahr O, Muller K, Franz K, Steinbach J, Hattingen E. Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients. J Neurooncol (2010) 99(1):49-56. doi:10.1007/s11060-009-0098-8
7. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol (2001) 22(6):1081-8.
8. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging (1999) 9(1):53-60. doi:10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2
9. White NS, Leergaard TB, D'Arceuil H, Bjaalie JG, Dale AM. Probing tissue microstructure with restriction spectrum imaging: histological and theoretical validation. Hum Brain Mapp (2013) 34(2):327-46. doi:10.1002/hbm.21454
10. Shah R, Vattoth S, Jacob R, Manzil FF, O'Malley JP, Borghei P, et al. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics (2012) 32(5):1343-59. doi:10.1148/rg.325125002